Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Ranganath Anil P. | 0001980144 | Jun-05-2023 | officer: See Remarks |
Corcoran Nicholas | 0001964148 | Jan-23-2023 | officer: See Remarks |
Godhani Rakesh P. | 0001876878 | Aug-04-2021 | officer: Chief Digital Officer |
Lovell Stephanie | 0001772054 | Mar-22-2021 | director |
RAINES MERILEE | 0001023869 | Jan-01-2021 | director |
DAMME LAURA | 0001784433 | Aug-05-2019 | officer: VP, Clinical Affairs |
UNITED THERAPEUTICS Corp | 0001082554 | May-01-2019 | 10 percent owner |
ABRAMS CAPITAL, LLC | 0001112443 | May-01-2019 | 10 percent owner |
ABRAMS CAPITAL MANAGEMENT, LLC | 0001165407 | May-01-2019 | 10 percent owner |
TOBIN JAMES R | 0001190128 | May-01-2019 | director |
AFEYAN NOUBAR | 0001222012 | May-01-2019 | 10 percent owner |
KANIA EDWIN M JR | 0001255927 | May-01-2019 | director |
Abrams David C | 0001292250 | May-01-2019 | 10 percent owner |
Abrams Capital Partners II, L.P. | 0001292420 | May-01-2019 | 10 percent owner |
Gilbert James | 0001312685 | May-01-2019 | director |
ABRAMS CAPITAL MANAGEMENT, L.P. | 0001358706 | May-01-2019 | 10 percent owner |
Khayal Tamer I | 0001430462 | May-01-2019 | officer: Chief Commercial Officer |
Hassanein Waleed H | 0001430466 | May-01-2019 | director, officer: President & CEO |
Flagship Ventures Fund IV, L.P. | 0001503559 | May-01-2019 | 10 percent owner |
Flagship Ventures Fund IV General Partner LLC | 0001508051 | May-01-2019 | 10 percent owner |
Flagship Ventures Fund 2007, L.P. | 0001508052 | May-01-2019 | 10 percent owner |
Flagship Ventures 2007 General Partner LLC | 0001508053 | May-01-2019 | 10 percent owner |
Riva Capital Partners III, L.P. | 0001525135 | May-01-2019 | 10 percent owner |
Gunderson Thomas James | 0001708144 | May-01-2019 | director |
Basile Edward M | 0001773661 | May-01-2019 | director |
Provost Miriam | 0001773663 | May-01-2019 | officer: VP of US Regulatory & FDA Rel. |
Weill David | 0001774270 | May-01-2019 | director |
Carey John F | 0001774272 | May-01-2019 | officer: VP of Operations |
Sullivan John F | 0001774273 | May-01-2019 | officer: VP of Quality & Engineering |
Gordon Stephen | 0001774274 | May-01-2019 | officer: Chief Financial Officer |
Lung Biotechnology PBC | 0001774528 | May-01-2019 | 10 percent owner |
Riva Capital Management III, LLC | 0001775371 | May-01-2019 | 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TransMedics Group, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-026492 ( Act) Size: 17 KB |
Mar-05-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-026478 ( Act) Size: 8 KB |
Mar-05-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-026472 ( Act) Size: 13 KB |
Mar-05-2024 | |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-001760 (33 Act) Size: 5 KB |
Mar-04-2024 | 24714386 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000167 (33 Act) Size: 4 KB |
Mar-01-2024 | 24712130 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-021330 ( Act) Size: 8 KB |
Feb-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-021328 ( Act) Size: 6 KB |
Feb-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-021334 ( Act) Size: 6 KB |
Feb-27-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-021329 ( Act) Size: 6 KB |
Feb-27-2024 | |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0000950170-24-021155 (34 Act) Size: 14247 KB |
Feb-27-2024 | 24686916 |
8-K | Document | Current report filing Acc-no: 0000950170-24-020175 (34 Act) Size: 427 KB |
Feb-26-2024 | 24679015 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-018047 ( Act) Size: 18 KB |
Feb-21-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-016560 ( Act) Size: 15 KB |
Feb-16-2024 | |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-034885 (34 Act) Size: 103 KB |
Feb-14-2024 | 24632033 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-022121 (34 Act) Size: 12 KB |
Feb-13-2024 | 24629712 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-013458 ( Act) Size: 10 KB |
Feb-09-2024 | |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-24-001557 (34 Act) Size: 8 KB |
Feb-09-2024 | 24612616 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-012810 ( Act) Size: 6 KB |
Feb-08-2024 | |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-000677 (33 Act) Size: 4 KB |
Feb-06-2024 | 24600231 |
8-K | Document | Current report filing Acc-no: 0001193125-24-025259 (34 Act) Size: 138 KB |
Feb-06-2024 | 24600222 |
Recent 20 filings. View all TransMedics Group, Inc. filings
young lad who new his job ansered questions and new what was best for me.
It's being easier working on the website. And I recommend, it's a great website
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by